Location: Boston, MA
CIK: 0001346824 · Show all filings
Period: Q4 2013 (← Previous) (Next →)
Filing Date: Feb 14, 2014
Total Value: $858M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ACAD | ACADIA PHARMACEUTICALS INC | 5,250,000 | $131M | 15.3% | $13.77 | +71.3% | Call | 004225108 |
| — | ACHILLION PHARMACEUTICALS IN | 23,366,007 | $77.55M | 9.0% | $4.78 | — | COM | 00448Q201 |
| SGMO | SANGAMO BIOSCIENCES INC | 5,227,272 | $72.61M | 8.5% | $9.24 | +24.6% | COM | 800677106 |
| — | THERAPEUTICSMD INC | 11,660,108 | $60.75M | 7.1% | $3.00 | — | COM | 88338N107 |
| — | NOVAVAX INC | 10,811,888 | $55.36M | 6.4% | $2.24 | — | COM | 670002104 |
| — | OPHTHOTECH CORP | 1,600,455 | $51.77M | 6.0% | $32.35 | — | COM | 683745103 |
| PRTA | PROTHENA CORP PLC | 1,641,167 | $43.52M | 5.1% | $15.16 | +65.5% | SHS | G72800108 |
| SGMO | SANGAMO BIOSCIENCES INC | 3,000,000 | $41.67M | 4.9% | $9.24 | +24.6% | Call | 800677106 |
| — | DYNAVAX TECHNOLOGIES CORP | 17,883,954 | $35.05M | 4.1% | $1.67 | — | COM | 268158102 |
| BCRX | BIOCRYST PHARMACEUTICALS | 4,347,456 | $33.04M | 3.8% | $5.07 | +24.8% | COM | 09058V103 |
| ACAD | ACADIA PHARMACEUTICALS INC | 1,169,898 | $29.24M | 3.4% | $13.77 | +71.3% | COM | 004225108 |
| XNCR | XENCOR INC | 2,725,000 | $24.91M | 2.9% | $8.58 | 0.0% | COM | 98401F105 |
| — | SUNESIS PHARMACEUTICALS INC | 4,869,261 | $23.08M | 2.7% | $5.18 | — | COM NEW | 867328601 |
| — | ARROWHEAD RESH CORP | 2,049,220 | $22.23M | 2.6% | $7.05 | — | COM NEW | 042797209 |
| — | DERMA SCIENCES INC | 1,994,876 | $21.59M | 2.5% | $13.35 | — | COM PAR $.01 | 249827502 |
| — | TESARO INC | 700,000 | $19.77M | 2.3% | $28.24 | — | COM | 881569107 |
| PTCT | PTC THERAPEUTICS INC | 752,438 | $12.77M | 1.5% | $17.50 | +0.4% | COM | 69366J200 |
| — | DYAX CORP | 1,619,697 | $12.2M | 1.4% | $3.46 | — | COM | 26746E103 |
| — | NEWLINK GENETICS CORP | 500,000 | $11.01M | 1.3% | $19.72 | — | Call | 651511107 |
| — | MIRATI THERAPEUTICS INC | 656,767 | $10.92M | 1.3% | $15.39 | — | COM | 60468T105 |
| — | ROCKWELL MED INC | 1,000,000 | $10.44M | 1.2% | — | — | Put | 774374102 |
| — | ACHILLION PHARMACEUTICALS IN | 3,000,000 | $9.957M | 1.2% | $4.78 | — | Call | 00448Q201 |
| — | BLUEBIRD BIO INC | 467,418 | $9.806M | 1.1% | $26.96 | — | COM | 09609G100 |
| — | OCERA THERAPEUTICS INC | 661,696 | $8.595M | 1.0% | $11.51 | — | COM | 67552A108 |
| — | ENZO BIOCHEM INC | 2,268,653 | $6.624M | 0.8% | $2.08 | — | COM | 294100102 |
| MGNX | MACROGENICS INC | 199,398 | $5.469M | 0.6% | $26.16 | 0.0% | COM | 556099109 |
| — | PSIVIDA CORP | 1,187,608 | $4.715M | 0.5% | $3.97 | — | COM | 74440J101 |
| — | DYAX CORP | 500,000 | $3.768M | 0.4% | $3.46 | — | Call | 26746E103 |
| — | MEI PHARMA INC | 408,333 | $3.271M | 0.4% | $8.01 | — | COM NEW | 55279B202 |
| — | CHELSEA THERAPEUTICS INTL LT | 666,667 | $2.957M | 0.3% | $4.44 | — | COM | 163428105 |
| — | CORONADO BIOSCIENCES INC | 1,000,000 | $2.63M | 0.3% | — | — | Call | 21976U109 |